| Argent Biopharma Limited (RGT) ORDINARY FULLY PAID |
Health Care |
$6 |
Appendix 4E and 2025 Annual Report
|
29 Aug 2025 5:35PM |
$0.130 |
$0.066 |
fallen by
49.23%
|
|
RGT - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant net loss and decrease in total assets.
- Commencement of supply of cannabinoid APIs to EU hospitals.
- Share-based payments and foreign currency impacts on equity.
- No significant contingent liabilities or commitments.
- Detailed disclosures on auditor's remuneration and related party transactions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Argent Biopharma Limited (RGT) ORDINARY FULLY PAID |
Health Care |
$6 |
Appendix 4E and 2025 Annual Report
|
29 Aug 2025 5:35PM |
$0.130 |
$0.066 |
fallen by
49.23%
|
|
RGT - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss of $17.84 million reported.
- Revenue decreased by 80% to $0.18 million.
- Focus on developing therapeutics for drug-resistant epilepsy and inflammatory disorders.
- Commenced supply of cannabinoid-based APIs for epilepsy treatment in the EU.
- Signed agreement to acquire AusCann Group Holdings Ltd's assets.
- Engaged in funding activities to support operations and strategic goals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Peppermint Innovation Limited (PIL) ORDINARY FULLY PAID |
Information Technology |
$10 |
Appendix 4E and Full Year Statutory Accounts
|
29 Aug 2025 5:34PM |
$0.003 |
$0.004 |
risen by
33.33%
|
|
PIL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased to $531,980 in 2025, from $1,273,842 in 2024.
- Net loss increased to $4,941,913 in 2025, from $4,442,021 in 2024.
- Significant expenses in research and development, employee benefits.
- Increase in issued capital alongside share issuance costs.
- Total assets decreased due to lower inventories and intangible assets.
- Cash and cash equivalents reduced at year-end despite positive financing cash flow.
- No significant post-reporting period events noted.
- Financial statements are being audited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Singular Health Group Ltd (SHG) ORDINARY FULLY PAID |
Health Care |
$86 |
Appendix 4E and Annual Report to Shareholders
|
29 Aug 2025 5:32PM |
$0.350 |
$0.275 |
fallen by
21.43%
|
|
SHG - Price-sensitive ASX Announcement
Full Release
Key Points
- Total comprehensive loss of $6,380,768 for the year ending 30 June 2025
- Significant loss after income tax expense amounting to $6,376,210
- Issued ordinary shares and managed equity-settled transactions
- Generated $14,483,559 in financing activities, increasing cash reserves
- Extensive details on share-based payments, including options and performance rights
- Granted 42,325,000 options during the year
- Directors' report includes remuneration and shareholding details
- Company confirms adherence to business objectives and strategic use of assets
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wellnex Life Limited (WNX) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Wellnex Releases FY25 Appendix 4E & Preliminary Report
|
29 Aug 2025 5:31PM |
$0.230 |
$0.095 |
fallen by
58.70%
|
|
WNX - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for FY25 was $23.6 million, a 40.4% increase from FY24.
- Gross profit increased by 38.4% to $6.9 million.
- EBITDA loss was $11.6 million, up 13.63%, impacted by non-cash expenses and transaction fees.
- Normalised EBITDA loss improved by 57% to $2.2 million.
- Net assets grew to $11.3 million, an 85.6% increase.
- Successful dual listing on the AIM market of the London Stock Exchange.
- Significant growth initiatives planned for FY26 to drive revenue and margin growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wellnex Life Limited (WNX) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Wellnex Releases FY25 Appendix 4E & Preliminary Report
|
29 Aug 2025 5:31PM |
$0.230 |
$0.095 |
fallen by
58.70%
|
|
WNX - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for FY25 increased by 40.4% to $23.6 million.
- Gross profit rose by 38% to $6.9 million.
- EBITDA loss increased to $11.6 million due to non-cash expenses.
- Normalised EBITDA loss improved by 57% to $2.2 million.
- Net assets increased by 85.6% to $11.3 million.
- Successful dual listing on the AIM market of the London Stock Exchange.
- Plans for further growth and licensing opportunities expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BetaShares Western Asset Australian Bond Fund (Managed Fund) (BNDS) |
Financials |
$846 |
Final Distribution Announcement
|
29 Aug 2025 5:31PM |
$24.000 |
$23.350 |
fallen by
2.71%
|
|
| Zicom Group Limited (ZGL) ORDINARY FULLY PAID |
Industrials |
$36 |
Appendix 4E and Preliminary Final Report 2025
|
29 Aug 2025 5:29PM |
$0.160 |
$0.165 |
risen by
3.13%
|
|
| New Age Exploration Limited (NAE) ORDINARY FULLY PAID |
Energy |
$13 |
Annual Report to Shareholders
|
29 Aug 2025 5:29PM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| Solara Minerals Limited (SLA) ORDINARY FULLY PAID |
Materials |
$12 |
Notification regarding unquoted securities - SLA
|
29 Aug 2025 5:28PM |
$0.190 |
$0.210 |
risen by
10.53%
|
|
| Mayfield Childcare Limited (MFD) ORDINARY FULLY PAID |
Consumer Discretionary |
$37 |
Mayfield Announces an Addition to the Board
|
29 Aug 2025 5:27PM |
$0.360 |
$0.490 |
risen by
36.11%
|
|
| SHAPE Australia Corporation Limited (SHA) ORDINARY FULLY PAID |
Industrials |
$518 |
Notification regarding unquoted securities - SHA
|
29 Aug 2025 5:27PM |
$4.020 |
$6.210 |
risen by
54.48%
|
|
| Synertec Corporation Limited (SOP) ORDINARY FULLY PAID |
Industrials |
$10 |
Appendix 4E and 2025 Annual Report
|
29 Aug 2025 5:27PM |
$0.027 |
$0.020 |
fallen by
25.93%
|
|
SOP - Price-sensitive ASX Announcement
Full Release
Key Points
- Synertec Corporation Limited reported a total revenue of $18.2 million for the year ending 30 June 2025, a decrease of 8% compared to the previous year.
- The Engineering segment experienced a slowdown, but the Technology segment saw a 90% increase in revenue.
- Powerhouse, a microgrid power system, significantly contributed to revenue growth with $2.0 million, up from $1.1 million the previous year.
- The company’s strategic focus on long-term contracts and repeat customers has been effective, with consultancy services representing over 90% of engineering revenue.
- Synertec was appointed to significant panels such as Western Australia’s Water Corporation and Sydney Water, providing substantial project opportunities.
- Environmental, Social, and Governance (ESG) efforts were highlighted, with significant reductions in emissions and active community engagement.
- An ongoing strategic partnership with PHNXX enables revenue through cross-referrals and licensing of control systems.
- The company maintained a strong commitment to governance, complying with ASX Corporate Governance principles.
- No dividends were declared, and the net loss for the year was reported at $7.6 million.
- Synertec continued to strengthen its environmental commitments, with total emissions reported at 2,951 tCO2e for the year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Synertec Corporation Limited (SOP) ORDINARY FULLY PAID |
Industrials |
$10 |
Appendix 4E and 2025 Annual Report
|
29 Aug 2025 5:27PM |
$0.027 |
$0.020 |
fallen by
25.93%
|
|
SOP - Price-sensitive ASX Announcement
Full Release
Key Points
- Synertec reported a financial loss of $7.64 million after tax for FY ending 30 June 2025.
- Total revenue for the year was $18.21 million, down from $19.79 million in the previous year.
- Loss attributable to owners of Synertec was consistent at $7.64 million.
- No dividends declared, paid, or recommended for the current year.
- Audited by Grant Thornton Audit Pty Ltd with no material misstatements reported.
- Focus on engineering services and technology contracts.
- ESG practices and corporate governance addressed in the report.
- Shareholder and management information, including key management personnel compensation, is disclosed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wellnex Life Limited (WNX) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Appendix 4E Preliminary Final Report
|
29 Aug 2025 5:26PM |
$0.230 |
$0.095 |
fallen by
58.70%
|
|
WNX - Price-sensitive ASX Announcement
Full Release
Key Points
- Wellnex Life Limited reported a post-tax loss of $15.6 million for FY 2025.
- Net cash used in operating activities was $666,000.
- The company maintains a going concern status despite financial challenges.
- Issued capital increased from $130.6 million to $151.4 million.
- Liabilities increased with a notable deficiency of $8.4 million over current assets.
- Strategic focus on high-margin revenue generation and market expansion.
- Capability to raise additional capital through placements if necessary.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wellnex Life Limited (WNX) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Appendix 4E Preliminary Final Report
|
29 Aug 2025 5:26PM |
$0.230 |
$0.095 |
fallen by
58.70%
|
|
WNX - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased to $23.6 million.
- Loss after tax was $15.6 million.
- Acquisition of Pain Away brand for $21.36 million.
- Share-based payments increased significantly.
- New loan facility of $2.825 million established post-year-end.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Artemis Resources Limited (ARV) ORDINARY FULLY PAID |
Materials |
$34 |
Results of Meeting
|
29 Aug 2025 5:25PM |
$0.006 |
$0.009 |
risen by
63.64%
|
|
| Infocus Group Holdings Limited (IFG) ORDINARY FULLY PAID |
Information Technology |
$8 |
Preliminary Final Report
|
29 Aug 2025 5:24PM |
$0.037 |
$0.017 |
fallen by
54.05%
|
|
IFG - Price-sensitive ASX Announcement
Full Release
Key Points
- Announcement of Preliminary Financial Results for FY2025
- Revenue from ordinary activities increased by 277.2%
- Net loss from ordinary activities increased by 19.7%
- Net Tangible Assets per Share decreased
- Accounts are in the process of being audited
- No dividends proposed
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Betashares Active Australian Hybrids Fund (Managed Fund) (HBRD) |
Financials |
$2,552 |
Quarterly Portfolio Disclosure
|
29 Aug 2025 5:20PM |
$10.160 |
$10.110 |
fallen by
0.49%
|
|
| Abacus Storage King (ASK) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,978 |
Notification regarding unquoted securities - ASK
|
29 Aug 2025 5:19PM |
$1.420 |
$1.505 |
risen by
5.99%
|
|
| Osteopore Limited (OSX) ORDINARY FULLY PAID |
Health Care |
$2 |
Half Yearly Report and Accounts
|
29 Aug 2025 5:18PM |
$0.012 |
$0.006 |
fallen by
50%
|
|
OSX - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for the half-year was AUD 1,558,847.
- Total comprehensive loss was AUD 1,772,741.
- No dividends declared or distributed.
- Increased focus on geographical segments: Singapore, Korea, and Australia.
- Consolidated total liabilities stood at AUD 4,615,967.
- Share capital increased through various placements.
- Continued product and business development efforts.
- Balance sheet adjustments included changes in financial assets and liabilities.
- Efforts to maintain asset base and strategic financial management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Osteopore Limited (OSX) ORDINARY FULLY PAID |
Health Care |
$2 |
Half Yearly Report and Accounts
|
29 Aug 2025 5:18PM |
$0.012 |
$0.006 |
fallen by
50%
|
|
OSX - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after income tax of $1,627,940.
- Total comprehensive loss of $1,772,741.
- Revenue from customers: $1,558,847.
- Total assets: $4,192,315; total liabilities: $4,615,967.
- Net liabilities of $423,652.
- Funds raised from share placements and convertible debt securities.
- Operations in Singapore, Korea, China, and Australia.
- Administrative and product development expenses major cost drivers.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| New Murchison Gold Limited (NMG) ORDINARY FULLY PAID |
Materials |
$530 |
Application for quotation of securities - NMG
|
29 Aug 2025 5:17PM |
$0.020 |
$0.049 |
risen by
145%
|
|
| Abacus Group (ABG) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,050 |
Notification regarding unquoted securities - ABG
|
29 Aug 2025 5:17PM |
$1.225 |
$1.175 |
fallen by
4.08%
|
|
| Central Petroleum Limited (CTP) ORDINARY FULLY PAID |
Energy |
$47 |
Change of Director's Interest Notice (L. Devaney)
|
29 Aug 2025 5:16PM |
$0.060 |
$0.063 |
risen by
5%
|
|
Call 1300 880 160
Start a chat
Schedule a call
